Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction

    Subclonal reconstruction algorithms use bulk DNA sequencing data to quantify parameters of tumor evolution, allowing an assessment of how cancers initiate, progress and respond to selective pressures. We launc...

    Adriana Salcedo, Maxime Tarabichi, Alex Buchanan in Nature Biotechnology (2024)

  2. Article

    Open Access

    Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features

    Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the...

    Srinivasa Rao, Clare Verrill, Lucia Cerundolo, Nasullah Khalid Alham in Genome Medicine (2024)

  3. Article

    Open Access

    Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

    Prostate cancer (PrCa) genomic heterogeneity causes resistance to therapies such as androgen deprivation. Such heterogeneity can be deciphered in the context of evolutionary principles, but current clinical tr...

    Anssi Nurminen, Serafiina Jaatinen, Sinja Taavitsainen, Gunilla Högnäs in Genome Medicine (2023)

  4. Article

    Open Access

    Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

    Bernardo Rodriguez-Martin, Eva G. Alvarez, Adrian Baez-Ortega in Nature Genetics (2023)

  5. Article

    Open Access

    The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia

    Luz Yurany Moreno Rueda, Dean Bryant, William J. Tapper, Nicola J. Weston-Bell in Leukemia (2023)

  6. Article

    Open Access

    Author Correction: The evolutionary history of 2,658 cancers

    Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C. Dentro in Nature (2023)

  7. Article

    Open Access

    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

    Up to 80% of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development. In the prese...

    Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker in Molecular Cancer (2022)

  8. Article

    Open Access

    African-specific molecular taxonomy of prostate cancer

    Prostate cancer is characterized by considerable geo-ethnic disparity. African ancestry is a significant risk factor, with mortality rates across sub-Saharan Africa of 2.7-fold higher than global averages1. The c...

    Weerachai Jaratlerdsiri, Jue Jiang, Tingting Gong, Sean M. Patrick, Cali Willet in Nature (2022)

  9. Article

    Open Access

    Clonal diversification and histogenesis of malignant germ cell tumours

    Germ cell tumours (GCTs) are a collection of benign and malignant neoplasms derived from primordial germ cells. They are uniquely able to recapitulate embryonic and extraembryonic tissues, which carries progno...

    Thomas R. W. Oliver, Lia Chappell, Rashesh Sanghvi in Nature Communications (2022)

  10. Article

    Open Access

    In utero origin of myelofibrosis presenting in adult monozygotic twins

    The latency between acquisition of an initiating somatic driver mutation by a single-cell and clinical presentation with cancer is largely unknown. We describe a remarkable case of monozygotic twins presenting...

    Nikolaos Sousos, Máire Ní Leathlobhair, Christina Simoglou Karali in Nature Medicine (2022)

  11. Article

    Open Access

    APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types

    The APOBEC3 (apolipoprotein B mRNA editing enzyme catalytic polypeptide 3) family of cytidine deaminases is responsible for two mutational signatures (SBS2 and SBS13) found in cancer genomes. APOBEC3 enzymes a...

    G. Maria Jakobsdottir, Daniel S Brewer, Colin Cooper, Catherine Green in BMC Biology (2022)

  12. Article

    Open Access

    Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes

    Black women across the African diaspora experience more aggressive breast cancer with higher mortality rates than white women of European ancestry. Although inter-ethnic germline variation is known, differenti...

    Naser Ansari-Pour, Yonglan Zheng, Toshio F. Yoshimatsu in Nature Communications (2021)

  13. No Access

    Article

    Genomic and evolutionary classification of lung cancer in never smokers

    Lung cancer in never smokers (LCINS) is a common cause of cancer mortality but its genomic landscape is poorly characterized. Here high-coverage whole-genome sequencing of 232 LCINS showed 3 subtypes defined b...

    Tongwu Zhang, Philippe Joubert, Naser Ansari-Pour, Wei Zhao in Nature Genetics (2021)

  14. No Access

    Article

    A unified haplotype-based method for accurate and comprehensive variant calling

    Almost all haplotype-based variant callers were designed specifically for detecting common germline variation in diploid populations, and give suboptimal results in other scenarios. Here we present Octopus, a ...

    Daniel P. Cooke, David C. Wedge, Gerton Lunter in Nature Biotechnology (2021)

  15. Article

    Open Access

    Promises and challenges of adoptive T-cell therapies for solid tumours

    Cancer is a leading cause of death worldwide and, despite new targeted therapies and immunotherapies, many patients with advanced-stage- or high-risk cancers still die, owing to metastatic disease. Adoptive T-...

    Matteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi in British Journal of Cancer (2021)

  16. Article

    Open Access

    Re-evaluating experimental validation in the Big Data Era: a conceptual argument

    Mohieddin Jafari, Yuanfang Guan, David C. Wedge, Naser Ansari-Pour in Genome Biology (2021)

  17. No Access

    Article

    A practical guide to cancer subclonal reconstruction from DNA sequencing

    Subclonal reconstruction from bulk tumor DNA sequencing has become a pillar of cancer evolution studies, providing insight into the clonality and relative ordering of mutations and mutational processes. We pro...

    Maxime Tarabichi, Adriana Salcedo, Amit G. Deshwar, Máire Ni Leathlobhair in Nature Methods (2021)

  18. No Access

    Article

    Genomic copy number predicts esophageal cancer years before transformation

    Recent studies show that aneuploidy and driver gene mutations precede cancer diagnosis by many years14. We assess whether these genomic signals can be used for early detection and pre-emptive cancer treatment us...

    Sarah Killcoyne, Eleanor Gregson, David C. Wedge, Dan J. Woodcock in Nature Medicine (2020)

  19. Article

    Open Access

    Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression

    Colorectal cancer (CRC) development is generally accepted as a sequential process, with genetic mutations determining phenotypic tumor progression. However, matching genetic profiles with histological transiti...

    Soulafa Mamlouk, Tincy Simon, Laura Tomás, David C. Wedge, Alexander Arnold in BMC Biology (2020)

  20. Article

    Open Access

    Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases

    Metastatic melanoma carries a poor prognosis despite modern systemic therapies. Understanding the evolution of the disease could help inform patient management. Through whole-genome sequencing of 13 melanoma m...

    Roy Rabbie, Naser Ansari-Pour, Oliver Cast, Doreen Lau in Nature Communications (2020)

previous disabled Page of 4